Selecting the wrong auto-injector platform can delay time to market, compromise patient safety and lead to costly recalls. MGS Design & Development’s platform assessment framework helps Pharma companies navigate this complex decision with confidence, built on years of experience in regulatory demands and device development.
In three steps, from mapping device-related activities to cataloging compatible platforms and evaluating vendor capabilities, the framework provides a clear foundation for choosing the best-fit device platform while minimizing risk and delay.